<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ecam.oxfordjournals.org">
<title>Evidence-based Complementary and Alternative Medicine - current issue</title>
<link>http://ecam.oxfordjournals.org</link>
<description>Evidence-based Complementary and Alternative Medicine - RSS feed of current issue</description>
<prism:eIssn>1741-4288</prism:eIssn>
<prism:coverDisplayDate>March 2010</prism:coverDisplayDate>
<prism:publicationName>Evidence-based Complementary and Alternative Medicine</prism:publicationName>
<prism:issn>1741-427X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/3?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/11?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/29?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/33?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/41?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/47?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/57?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/63?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/69?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/79?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/87?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/97?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/107?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/115?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/121?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/129?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/137?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/7/1/145?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/1?rss=1">
<title><![CDATA[eCAM: Proteomics, BioArt and Integrative Medicine?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:29 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep235</dc:identifier>
<dc:title><![CDATA[eCAM: Proteomics, BioArt and Integrative Medicine?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>2</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>1</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/3?rss=1">
<title><![CDATA[Traditional Chinese Medicine for Chronic Fatigue Syndrome]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/3?rss=1</link>
<description><![CDATA[
<p>More and more patients have been diagnosed as having chronic fatigue syndrome (CFS) in recent years. Western drug use for this syndrome is often associated with many side-effects and little clinical benefit. As an alternative medicine, traditional Chinese medicine (TCM) has provided some evidences based upon ancient texts and recent studies, not only to offer clinical benefit but also offer insights into their mechanisms of action. It has perceived advantages such as being natural, effective and safe to ameliorate symptoms of CFS such as fatigue, disordered sleep, cognitive handicaps and other complex complaints, although there are some limitations regarding the diagnostic standards and methodology in related clinical or experimental studies. Modern mechanisms of TCM on CFS mainly focus on adjusting immune dysfunction, regulating abnormal activity in the hypothalamic-pituitary-adrenal (HPA) axis and serving as an antioxidant. It is vitally important for the further development to establish standards for &lsquo;zheng&rsquo; of CFS, i.e. the different types of CFS pathogenesis in TCM, to perform randomized and controlled trials of TCM on CFS and to make full use of the latest biological, biochemical, molecular and immunological approaches in the experimental design.</p>
]]></description>
<dc:creator><![CDATA[Chen, R., Moriya, J., Yamakawa, J.-i., Takahashi, T., Kanda, T.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:29 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen017</dc:identifier>
<dc:title><![CDATA[Traditional Chinese Medicine for Chronic Fatigue Syndrome]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>10</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>3</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/11?rss=1">
<title><![CDATA[Who Uses CAM? A Narrative Review of Demographic Characteristics and Health Factors Associated with CAM Use]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/11?rss=1</link>
<description><![CDATA[
<p>Complementary and Alternative Medicines (CAM) are used by an extensive number of patients in the UK and elsewhere. In order to understand this pattern of behavior, it is helpful to examine the characteristics of people who use CAM. This narrative review collates and evaluates the evidence concerning the demographic characteristics and health status factors associated with CAM use in community-based non-clinical populations. A systematic literature search of computerized databases was conducted, and published research papers which present evidence concerning associations between CAM use and demographic and health characteristics are discussed and evaluated. The evidence suggests that people who use CAM tend to be female, of middle age and have more education. In terms of their health, CAM users tend to have more than one medical condition, but might not be more likely than non-users to have specific conditions such as cancer or to rate their own general health as poor. The multivariate studies that have been conducted suggest that both demographic and health characteristics contribute independently to CAM use. In conclusion, demographic characteristics and factors related to an individual's health status are associated with CAM use. Future research is needed to address methodological limitations in existing studies.</p>
]]></description>
<dc:creator><![CDATA[Bishop, F. L., Lewith, G. T.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:29 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen023</dc:identifier>
<dc:title><![CDATA[Who Uses CAM? A Narrative Review of Demographic Characteristics and Health Factors Associated with CAM Use]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>28</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>11</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/29?rss=1">
<title><![CDATA[Geffen Faculty Highlight Concerns Linking CAIM and Conventional Researchers at UCLA Symposium]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/29?rss=1</link>
<description><![CDATA[
<p>David Geffen School of Medicine faculty, representing a wide range of disciplines, engaged speakers nationally known for their expertise on complementary, alternative and integrative medicine (CAIM) and its investigation at a January, 2008 symposium on the campus of the University of California, Los Angeles. The forum was created to educate the UCLA Institutional Review Board (IRB), and lively participation by School of Medicine faculty helped bring IRB members up to speed on controversies surrounding CAIM research. The symposium demonstrated that academics who are neither proponents nor detractors of CAIM can facilitate cross talk between opposing camps, elucidating questions important to its evaluation by those charged with protecting research subjects. It also brought attention to the universality of quandaries facing CAIM investigators and to the ingenuity with which they have addressed many of them.</p>
]]></description>
<dc:creator><![CDATA[Logue, E. H.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:29 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen051</dc:identifier>
<dc:title><![CDATA[Geffen Faculty Highlight Concerns Linking CAIM and Conventional Researchers at UCLA Symposium]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>32</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>29</prism:startingPage>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/33?rss=1">
<title><![CDATA[The Curious Case of Charles Darwin and Homeopathy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/33?rss=1</link>
<description><![CDATA[
<p>In 1849, Charles Darwin was so ill that he was unable to work one out of every 3 days, and after having various troubling symptoms for 2&ndash;12 years, he wrote to a friend that he was &lsquo;going the way of all flesh&rsquo;. He sought treatment from Dr James Manby Gully, a medical doctor who used water cure and homeopathic medicines. Despite being highly skeptical of these treatments, he experienced a dramatic improvement in his health, though some of his digestive and skin symptoms returned various times in his life. He grew to appreciate water cure, but remained skeptical of homeopathy, even though his own experiments on insectivore plants using what can be described as homeopathic doses of ammonia salts surprised and shocked him with their significant biological effect. Darwin even expressed concern that he should publish these results. Two of Darwin's sons were as incredulous as he was, but their observations confirmed the results of his experiments. Darwin was also known to have read a book on evolution written by a homeopathic physician that Darwin described as similar to his own but &lsquo;goes much deeper.&rsquo;</p>
]]></description>
<dc:creator><![CDATA[Ullman, D.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep168</dc:identifier>
<dc:title><![CDATA[The Curious Case of Charles Darwin and Homeopathy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>39</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>33</prism:startingPage>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/41?rss=1">
<title><![CDATA[Inhibitory Potencies of Several Iridoids on Cyclooxygenase-1, Cyclooxygnase-2 Enzymes Activities, Tumor Necrosis factor-{alpha} and Nitric Oxide Production In Vitro]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/41?rss=1</link>
<description><![CDATA[
<p>To verify the anti-inflammatory potency of iridoids, seven iridoid glucosides (aucubin, catalpol, gentiopicroside, swertiamarin, geniposide, geniposidic acid and loganin) and an iridoid aglycone (genipin) were investigated with <I>in vitro</I> testing model systems based on inhibition of cyclooxygenase (COX)-1/-2 enzymes, the tumor necrosis factor- (TNF-) formation and nitric oxide (NO) production. The hydrolyzed-iridoid products (H-iridoid) with &beta;-gludosidase treatment only showed inhibitory activities, and revealed different potencies, depending on their chemical structures. Without the &beta;-gludosidase treatment, no single iridoid glycoside exhibited any activities. The aglycone form (genipin) also did not show inhibitory activities. To compare anti-inflammatory potency, the inhibitory concentrations (IC<SUB>50</SUB>) in each testing system were measured. The hydrolyzed-aucubin product (H-aucubin) with &beta;-gludosidase treatment showed a moderate inhibition on COX-2 with IC<SUB>50</SUB> of 8.83 &micro;M, but much less inhibition (IC<SUB>50</SUB>, 68.9 &micro;M) on COX-1 was noted. Of the other H-iridoid products, the H-loganin and the H-geniposide exhibited higher inhibitory effects on COX-1, revealing IC<SUB>50</SUB> values of 3.55 and 5.37 &micro;M, respectively. In the case of TNF- assay, four H-iridoid products: H-aucubin, H-catalpol, H-geniposide and H-loganin suppressed the TNF- formation with IC<SUB>50</SUB> values of 11.2, 33.3, 58.2 and 154.6 &micro;M, respectively. But other H-iridoid products manifested no significant activity. Additional experiments on NO production were conducted. We observed that only the H-aucubin exhibited a significant suppression with IC<SUB>50</SUB> value of 14.1 &micro;M. Genipin, an agycone form, showed no inhibitory effects on all testing models, implying the hydrolysis of the glycosidic bond of iridoid glycoside is a pre-requisite step to produce various biological activities.</p>
]]></description>
<dc:creator><![CDATA[Park, K. S., Kim, B. H., Chang, I.-M.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem129</dc:identifier>
<dc:title><![CDATA[Inhibitory Potencies of Several Iridoids on Cyclooxygenase-1, Cyclooxygnase-2 Enzymes Activities, Tumor Necrosis factor-{alpha} and Nitric Oxide Production In Vitro]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>45</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>41</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/47?rss=1">
<title><![CDATA[Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/47?rss=1</link>
<description><![CDATA[
<p><I>Vaccinium myrtillus</I> (Bilberry) extracts (VME) were tested for effects on angiogenesis <I>in vitro</I> and <I>in vivo</I>. VME (0.3&ndash;30 &micro;g ml<sup>&ndash;1</sup>) and GM6001 (0.1&ndash;100 &micro;M; a matrix metalloproteinase inhibitor) concentration-dependently inhibited both tube formation and migration of human umbilical vein endothelial cells (HUVECs) induced by vascular endothelial growth factor-A (VEGF-A). In addition, VME inhibited VEGF-A-induced proliferation of HUVECs. VME inhibited VEGF-A-induced phosphorylations of extracellular signal-regulated kinase 1/2 (ERK 1/2) and serine/threonine protein kinase family protein kinase B (Akt), but not that of phospholipase C (PLC). In an <I>in vivo</I> assay, intravitreal administration of VME inhibited the formation of neovascular tufts during oxygen-induced retinopathy in mice. Thus, VME inhibited angiogenesis both <I>in vitro</I> and <I>in vivo</I>, presumably by inhibiting the phosphorylations of ERK 1/2 and Akt. These findings indicate that VME may be effective against retinal diseases involving angiogenesis, providing it can reach the retina after its administration. Further investigations will be needed to clarify the major angiogenesis-modulating constituent(s) of VME.</p>
]]></description>
<dc:creator><![CDATA[Matsunaga, N., Chikaraishi, Y., Shimazawa, M., Yokota, S., Hara, H.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem151</dc:identifier>
<dc:title><![CDATA[Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>56</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>47</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/57?rss=1">
<title><![CDATA[In vitro Evaluation of the Antiviral Activity of an Extract of Date Palm (Phoenix dactylifera L.) Pits on a Pseudomonas Phage]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/57?rss=1</link>
<description><![CDATA[
<p>A crude acetone extract of the pit of date palm (<I>Phoenix dactylifera</I> L.) was prepared and its antiviral activity evaluated against lytic <I>Pseudomonas</I> phage ATCC 14209-B1, using <I>Pseudomonas aeruginosa</I> ATCC 25668 as the host cell. The antiviral activity of date pits was found to be mediated by binding to the phage, with minimum inhibitory concentration (MIC) of &lt;10 &micro;g ml<sup>&ndash;1</sup>. The decimal reduction time (<I>D</I>-values), the concentration exponent () and the phage inactivation kinetics were determined. The date pit extracts show a strong ability to inhibit the infectivity of <I>Pseudomonas</I> phage ATCC 14209-B1 and completely prevented bacterial lysis, which it is hoped will promote research into its potential as a novel antiviral agent against pathogenic human viruses.</p>
]]></description>
<dc:creator><![CDATA[Jassim, S. A. A., Naji, M. A.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem160</dc:identifier>
<dc:title><![CDATA[In vitro Evaluation of the Antiviral Activity of an Extract of Date Palm (Phoenix dactylifera L.) Pits on a Pseudomonas Phage]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>62</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>57</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/63?rss=1">
<title><![CDATA[AMP N1-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/63?rss=1</link>
<description><![CDATA[
<p>Earlier we identified adenosine monophosphate (AMP) <I>N</I><SUB>1</SUB>-oxide as a unique compound of royal jelly (RJ) that induces neurite outgrowth (neuritegenesis) from cultured rat pheochromocytoma PC12 cells via the adenosine A<SUB>2A</SUB> receptor. Now, we found that AMP <I>N</I><SUB>1</SUB>-oxide stimulated the phosphorylation of not only mitogen-activated protein kinase (MAPK) but also that of cAMP/calcium-response element-binding protein (CREB) in a dose-dependent manner. Inhibition of MAPK activation by a MEK inhibitor, PD98059, did not influence the AMP <I>N</I><SUB>1</SUB>-oxide-induced neuritegenesis, whereas that of protein kinase A (PKA) by a selective inhibitor, KT5720, significantly reduced neurite outgrowth. AMP <I>N</I><SUB>1</SUB>-oxide also had the activity of suppressing the growth of PC12 cells, which correlated well with the neurite outgrowth-promoting activity. KT5720 restored the growth of AMP <I>N</I><SUB>1</SUB>-oxide-treated PC12 cells. It is well known that nerve growth factor suppresses proliferation of PC12 cells before causing stimulation of neuronal differentiation. Thus, AMP <I>N</I><SUB>1</SUB>-oxide elicited neuronal differentiation of PC12 cells, as evidenced by generation of neurites, and inhibited cell growth through adenosine A<SUB>2A</SUB> receptor-mediated PKA signaling, which may be responsible for characteristic actions of RJ.</p>
]]></description>
<dc:creator><![CDATA[Hattori, N., Nomoto, H., Fukumitsu, H., Mishima, S., Furukawa, S.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem146</dc:identifier>
<dc:title><![CDATA[AMP N1-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>68</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>63</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/69?rss=1">
<title><![CDATA[Hochuekkito, a Kampo (traditional Japanese herbal) Medicine, Enhances Mucosal IgA Antibody Response in Mice Immunized with Antigen-entrapped Biodegradable Microparticles]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/69?rss=1</link>
<description><![CDATA[
<p>The effect of oral administration of Hochuekkito (HET; Bu-Zhong-Yi-Qi-Tang in Chinese), a traditional Japanese herbal medicine, on mucosal IgA immune response was investigated. To induce the antigen-specific antibodies in mucosal site, ovalbumin (OVA)-entrapped biodegradable microparticles (OVA-microparticles) were used as an antigen. Mice were orally immunized with OVA-microparticles for 3 successive days with intragastric gavage. From 7 days after the onset of immunization, the mice were boosted twice a week with the same antigen for 2 weeks. HET or water alone was orally administered to the mice via the intragastric route from 7 days before to 27 days after the onset of immunization. Although no significant change in total secretory IgA antibody level was observed in intestinal and nasal washes, OVA-specific IgA titers in intestinal washes were significantly enhanced by oral administration of HET. When lymphocytes from spleen, peripheral blood and Payer's patches were investigated for cytokines production, it was found that the IFN- secretion from the lymphocytes was increased by the administration of HET. Microarray analysis of Peyer's patch cells revealed enhanced expression of L-selectin gene. The increase of L-selectin positive cells in B lymphocytes fraction was observed in Peyer's patch cells and peripheral blood mononuclear cells by flow cytometry. These results suggest that the enhanced IFN- secretion and increased population of L-selectin positive B lymphocytes by orally administered HET may partly contribute to enhancement of IgA immune response against intestinal antigens, and orally administered HET may strengthen defensive systems against various pathogens and food antigens in intestine.</p>
]]></description>
<dc:creator><![CDATA[Matsumoto, T., Noguchi, M., Hayashi, O., Makino, K., Yamada, H.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem166</dc:identifier>
<dc:title><![CDATA[Hochuekkito, a Kampo (traditional Japanese herbal) Medicine, Enhances Mucosal IgA Antibody Response in Mice Immunized with Antigen-entrapped Biodegradable Microparticles]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>77</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>69</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/79?rss=1">
<title><![CDATA[Anti-inflammatory and Immune-regulatory Effects of Subcutaneous Perillae Fructus Extract Injections on OVA-induced Asthma in Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/79?rss=1</link>
<description><![CDATA[
<p><I>Perillae fructus</I> (perilla seed) is a traditional medicinal herb used to treat bronchial asthma in Oriental medical clinics. ST36 is one of the most widely used acupuncture points, particularly for immune system regulation. Injection of an herbal extract into an acupuncture point (herbal acupuncture) is a therapeutic technique combining both acupuncture and herbal treatment. <I>Perillae fructus</I> extract was injected subcutaneously (<I>Perillae fructus</I> herbal acupuncture; PF-HA) at acupoint ST36 of OVA-induced asthmatic mice. The lung weight, bronchoalveolar fluid (BALF) cell count, the number of CCR3+, CD11b+, CD4+ and CD3e+/CD69+ cells in the lung, and the level of IgE, IL-4, IL-5 and IL-13 in BALF and serum were then measured. RT-PCR was used to measure the mRNA expression of IL-4, IL-5, IL-13 and TNF- in the lung. Lung sections were analyzed histologically. PF-HA significantly reduced lung weight, the number of inflammatory cells in the lung and BALF, the levels of IgE and Th2 cytokines in BALF and serum, mRNA expression of Th2 cytokines in the lung, and pathological changes in lung tissue. Our results suggest that PF-HA may have an anti-inflammatory and immune-regulatory effect on bronchial allergic asthma by restoring the Th1/Th2 imbalance in the immune system and suppressing eosinophilic inflammation in airways.</p>
]]></description>
<dc:creator><![CDATA[Yim, Y.-K., Lee, H., Hong, K.-E., Kim, Y.-I., Ko, S.-K., Kim, J.-E., Lee, S.-Y., Park, K.-S.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem118</dc:identifier>
<dc:title><![CDATA[Anti-inflammatory and Immune-regulatory Effects of Subcutaneous Perillae Fructus Extract Injections on OVA-induced Asthma in Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>86</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>79</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/87?rss=1">
<title><![CDATA[A Kampo Medicine, Boi-ogi-to, Inhibits Obesity in Ovariectomized Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/87?rss=1</link>
<description><![CDATA[
<p>In women facing menopause, end of menstrual activity is accompanied by lower levels of estrogen and gradual weight gain. Postmenopausal weight gain sounds an alarm for women's health and may lead to hyperlipidemia, a lipid increase and glucose intolerance. These phenomena are connected to lifestyle-related diseases such as hypertension, type II diabetes mellitus, arteriosclerosis and metabolic syndrome, making it essential to prevent weight gain in women. A Kampo medicine, Boi-ogi-to, is traditionally used to treat obese conditions, but the mechanism has not yet been investigated. In this experiment, we tested the antiobesity properties of Boi-ogi-to in ovariectomized rats by measuring changes of serum cytokine levels and adipocytokines in fat cells. After treatment with this extract for 6 weeks (20-week-old rats), we found that there was a significant weight decrease in rats treated with Boi-ogi-to as compared with that in the control group. Serum tumor necrosis factor (TNF)- levels increased significantly in a dose-dependent manner. Gene expression of adipose tissue in uterus also dose dependently showed a significant increase of TNF- levels, suggesting that secretion of TNF- by fat cells might play a role in the ability of Boi-ogi-to to inhibit weight gain. While peroxisome proliferators-activated receptor- and adiponectin levels did not show a significant difference as compared with those in the control, levels of mRNA expression showed a tendency to increase dose dependently. Resistin did not show any significant change. These results suggest that Boi-ogi-to might be useful for the prevention of obesity that occurs in women with reduction of estrogen.</p>
]]></description>
<dc:creator><![CDATA[Yamakawa, J.-i., Moriya, J., Takahashi, T., Ishige, A., Motoo, Y., Yoshizaki, F., Kanda, T.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem153</dc:identifier>
<dc:title><![CDATA[A Kampo Medicine, Boi-ogi-to, Inhibits Obesity in Ovariectomized Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>95</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>87</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/97?rss=1">
<title><![CDATA[N-butanol Extract from Melilotus Suaveolens Ledeb Affects Pro- and Anti-Inflammatory Cytokines and Mediators]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/97?rss=1</link>
<description><![CDATA[
<p><I>Melilotus suaveolens Ledeb</I> is a traditional medicinal plant for treating inflammation-related disease. This explores the inner anti-inflammatory mechanism of <I>n</I>-butanol extract from <I>M. suaveolens Ledeb</I>. Inflammatory cellular model was established by lipopolysaccharide intervention on RAW264.7 cell line. Levels of secreted cytokines TNF-, IL-1&beta;, IL-6, NO and IL-10 in supernatant, mRNA expression of TNF-, COX-2, iNOS and HO-1, protein expression of COX-2 and HO-1, activation of NF-B and ingredients in the extract were assayed by ELISA, real time quantitative PCR, western blot, immunocytochemical test and HPLC fingerprint test, respectively. As a result, the extract could not only markedly reduce the production of pro-inflammatory mediators to different extents by blocking NF-B activation but also promote the release of anti-inflammatory mediator HO-1 significantly. Each 1 g extract contained 0.023531 mg coumarin and another two high polar ingredients, probably saponins. It can be concluded that the extract has similar effects on antagonizing pro-inflammatory mediators and cytokines like Dexamethasone, and has effects on promoting the production of anti-inflammatory mediators.</p>
]]></description>
<dc:creator><![CDATA[Zhao, L., Tao, J.-Y., Zhang, S.-L., Jin, F., Pang, R., Dong, J.-H.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem165</dc:identifier>
<dc:title><![CDATA[N-butanol Extract from Melilotus Suaveolens Ledeb Affects Pro- and Anti-Inflammatory Cytokines and Mediators]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>106</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>97</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/107?rss=1">
<title><![CDATA[Dietary Supplement Polypharmacy: An Unrecognized Public Health Problem?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/107?rss=1</link>
<description><![CDATA[
<p>Excessive and inappropriate use of medications, or &lsquo;polypharmacy&rsquo;, has been recognized as a public health problem. In addition, there is growing use of dietary supplements in the United States; however, little is known about the patterns of supplement use. Recent reports in the literature of cases of excessive or inappropriate use of herbal dietary supplements leading to the term &lsquo;polyherbacy&rsquo;. The clinical vignettes described in this article highlight the need for further research on the nature and extent of multiple and inappropriate dietary supplement use or &lsquo;dietary supplement polypharmacy&rsquo;. Clinical interviewing and population surveys both address this issue in complementary ways, and provide a further understanding of dietary supplement use patterns.</p>
]]></description>
<dc:creator><![CDATA[Nisly, N. L., Gryzlak, B. M., Zimmerman, M. B., Wallace, R. B.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem150</dc:identifier>
<dc:title><![CDATA[Dietary Supplement Polypharmacy: An Unrecognized Public Health Problem?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>113</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>107</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/115?rss=1">
<title><![CDATA[Potential Use of Plectranthus amboinicus in the Treatment of Rheumatoid Arthritis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/115?rss=1</link>
<description><![CDATA[
<p><I>Plectranthus amboinicus</I> (<I>P. amboinicus</I>) is a folk herb that is used to treat inflammatory diseases or swelling symptoms in Taiwan. We investigated therapeutic efficacy of <I>P. amboinicus</I> in treating Rheumatoid Arthritis (RA) using collagen-induced arthritis animal model. Arthritis was induced in Lewis rats by immunization with bovine type II collagen. Serum anti-collagen IgG, IgM and C-reactive protein (CRP) were analyzed. To understand the inflammation condition of treated animals, production of TNF-, IL-6 and IL-1&beta; from peritoneal exudates cells (PEC) were also analyzed. <I>P. amboinicus</I> significantly inhibited the footpad swelling and arthritic symptoms in collagen-induced arthritic rats, while the serum anti-collagen IgM and CRP levels were consistently decreased. The production of pro-inflammatory cytokines TNF-, IL-6 and IL-1&beta; were also decreased in the high dosage of <I>P. amboinicus</I> group. Here, we demonstrate the potential anti-arthritic effect of <I>P. amboinicus</I> for treating RA, which might confer its anti-rheumatic activity. This differs the pharmacological action mode of indomethacin.</p>
]]></description>
<dc:creator><![CDATA[Chang, J.-M., Cheng, C.-M., Hung, L.-M., Chung, Y.-S., Wu, R.-Y.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem168</dc:identifier>
<dc:title><![CDATA[Potential Use of Plectranthus amboinicus in the Treatment of Rheumatoid Arthritis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>120</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>115</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/121?rss=1">
<title><![CDATA[Regional Brain Activation During Meditation Shows Time and Practice Effects: An Exploratory FMRI Study{dagger}]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/121?rss=1</link>
<description><![CDATA[
<p>Meditation involves attentional regulation and may lead to increased activity in brain regions associated with attention such as dorsal lateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC). Using functional magnetic resonance imaging, we examined whether DLPFC and ACC were activated during meditation. Subjects who meditate were recruited and scanned on a 3.0 Tesla scanner. Subjects meditated for four sessions of 12 min and performed four sessions of a 6 min control task. Individual and group t-maps were generated of overall meditation response versus control response and late meditation response versus early meditation response for each subject and time courses were plotted. For the overall group (<I>n</I> = 13), and using an overall brain analysis, there were no statistically significant regional activations of interest using conservative thresholds. A region of interest analysis of the entire group time courses of DLPFC and ACC were statistically more active throughout meditation in comparison to the control task. Moreover, dividing the cohort into short (<I>n</I> = 8) and long-term (<I>n</I> = 5) practitioners (&gt;10 years) revealed that the time courses of long-term practitioners had significantly more consistent and sustained activation in the DLPFC and the ACC during meditation versus control in comparison to short-term practitioners. The regional brain activations in the more practised subjects may correlate with better sustained attention and attentional error monitoring. In summary, brain regions associated with attention vary over the time of a meditation session and may differ between long- and short-term meditation practitioners.</p>
]]></description>
<dc:creator><![CDATA[Baron Short, E., Kose, S., Mu, Q., Borckardt, J., Newberg, A., George, M. S., Kozel, F. A.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem163</dc:identifier>
<dc:title><![CDATA[Regional Brain Activation During Meditation Shows Time and Practice Effects: An Exploratory FMRI Study{dagger}]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>127</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>121</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/129?rss=1">
<title><![CDATA[Can Homeopathy Bring Additional Benefits to Thalassemic Patients on Hydroxyurea Therapy? Encouraging Results of a Preliminary Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/129?rss=1</link>
<description><![CDATA[
<p>Several homeopathic remedies, namely, Pulsatilla Nigricans (30th potency), Ceanothus Americanus (both mother tincture and 6th potency) and Ferrum Metallicum (30th potency<b>)</b> selected as per similia principles were administered to 38 thalassemic patients receiving Hydroxyurea (HU) therapy for a varying period of time. Levels of serum ferritin (SF), fetal hemoglobin (HbF), hemoglobin (Hb), platelet count (PC), mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular hemoglobin (MCH), white blood cell (WBC) count, bilirubin content, alanine amino transferase (ALT), aspartate amino transferase (AST) and serum total protein content of patients were determined before and 3 months after administration of the homeopathic remedies in combination with HU to evaluate additional benefits, if any, derived by the homeopathic remedies, by comparing the data with those of 38 subjects receiving only HU therapy. Preliminary results indicated that there was a significant decrease in the SF and increase in HbF levels in the combined, treated subjects. Although the changes in other parameters were not so significant, there was a significant decrease in size of spleen in most patients with spleenomegaly and improvement in general health conditions along with an increased gap between transfusions in most patients receiving the combined homeopathic treatment. The homeopathic remedies being inexpensive and without any known side-effects seem to have great potentials in bringing additional benefits to thalassemic patients; particularly in the developing world where blood transfusions suffer from inadequate screening and fall short of the stringent safety standards followed in the developed countries. Further independent studies are encouraged.</p>
]]></description>
<dc:creator><![CDATA[Banerjee, A., Chakrabarty, S. B., Karmakar, S. R., Chakrabarty, A., Biswas, S. J., Haque, S., Das, D., Paul, S., Mandal, B., Naoual, B., Belon, P., Khuda-Bukhsh, A. R.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:30 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem161</dc:identifier>
<dc:title><![CDATA[Can Homeopathy Bring Additional Benefits to Thalassemic Patients on Hydroxyurea Therapy? Encouraging Results of a Preliminary Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>136</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>129</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/137?rss=1">
<title><![CDATA[Mucuna pruriens Reduces Stress and Improves the Quality of Semen in Infertile Men]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/137?rss=1</link>
<description><![CDATA[
<p>The present investigation was undertaken to assess the role of <I>Mucuna pruriens</I> in infertile men who were under psychological stress. Study included 60 subjects who were undergoing infertility screening and were found to be suffering from psychological stress, assessed on the basis of a questionnaire and elevated serum cortisol levels. Age-matched 60 healthy men having normal semen parameters and who had previously initiated at least one pregnancy were included as controls. Infertile subjects were administered with <I>M. pruriens</I> seed powder (5 g day<sup>&ndash;1</sup>) orally. For carrying out morphological and biochemical analysis, semen samples were collected twice, first before starting treatment and second after 3 months of treatment. The results demonstrated decreased sperm count and motility in subjects who were under psychological stress. Moreover, serum cortisol and seminal plasma lipid peroxide levels were also found elevated along with decreased seminal plasma glutathione (GSH) and ascorbic acid contents and reduced superoxide dismutase (SOD) and catalase activity. Treatment with <I>M. pruriens</I> significantly ameliorated psychological stress and seminal plasma lipid peroxide levels along with improved sperm count and motility. Treatment also restored the levels of SOD, catalase, GSH and ascorbic acid in seminal plasma of infertile men. On the basis of results of the present study, it may be concluded that <I>M. pruriens</I> not only reactivates the anti-oxidant defense system of infertile men but it also helps in the management of stress and improves semen quality.</p>
]]></description>
<dc:creator><![CDATA[Shukla, K. K., Mahdi, A. A., Ahmad, M. K., Jaiswar, S. P., Shankwar, S. N., Tiwari, S. C.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:31 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem171</dc:identifier>
<dc:title><![CDATA[Mucuna pruriens Reduces Stress and Improves the Quality of Semen in Infertile Men]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>144</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>137</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/7/1/145?rss=1">
<title><![CDATA['The Science of CAIM: What's Next for Complementary, Alternative and Integrative Medical Research?']]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/7/1/145?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Logue, E. H.]]></dc:creator>
<dc:date>Wed, 03 Feb 2010 19:56:31 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen028</dc:identifier>
<dc:title><![CDATA['The Science of CAIM: What's Next for Complementary, Alternative and Integrative Medical Research?']]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>147</prism:endingPage>
<prism:publicationDate>2010-03-01</prism:publicationDate>
<prism:startingPage>145</prism:startingPage>
<prism:section>Meeting Report</prism:section>
</item>

</rdf:RDF>